GlassScriptPhysician profile
John P Welch
NPI 1912228495
$5,675.73
in general payments reported to CMS, 2019-2025
26 companies · $2,088 in 2025
The $2,088 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $609 · 2022: $584 · 2023: $383 · 2024: $2,012 · 2025: $2,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,483.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,718.83 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Spinal Simplicity, LLC | $1,169.34 | 2023-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $533.31 | 2021-2025 | Proclaim |
| Curonix LLC | $502.11 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $360.65 | 2022-2024 | |
| Mml US, INC. | $165.74 | 2024 | Reactiv8 |
| Tersera Therapeutics LLC | $157.59 | 2021-2023 | Prialt |
| Collegium Pharmaceutical, INC. | $145.29 | 2021-2023 | Xtampza |
| Vertos Medical, INC. | $144.82 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.03 | 2021-2023 | Relistor |
| Scilex Pharmaceuticals INC. | $95.66 | 2022-2024 | |
| Allergan, INC. | $66.33 | 2021-2022 | |
| Nevro Corp. | $65.79 | 2021-2024 | Senza |
| Medtronic, INC. | $62.58 | 2021-2022 | |
| Relievant Medsystems, INC. | $61.64 | 2021-2023 | Intracept |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $61.56 | 2021-2022 | |
| Amgen INC. | $55.80 | 2021-2024 | Evenity, Prolia |
| Biodelivery Sciences International, INC. | $49.53 | 2021 | |
| Spr Therapeutics, INC | $35.34 | 2024 | Sprint Pns System |
| Stimwave Technologies Incorporated | $26.22 | 2021 | |
| Almatica Pharma LLC | $20.52 | 2023 | Gralise |
| Biohaven Pharmaceutical Holding Company LTD. | $19.78 | 2022 | |
| Saluda Medical Americas, INC. | $19.23 | 2025 | Evoke |
| Globus Medical, INC. | $16.38 | 2025 | Senza |
| Pacira Therapeutics, INC. | $11.43 | 2021 | |
| Lilly USA, LLC | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.